TrialArthritis & rheumatology (Hoboken, N.J.)2022

Phase III/IV, Randomized, Fifty-Two-Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus.

Ellen Ginzler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.